174 related articles for article (PubMed ID: 19643254)
1. Differential expression of SKI oncogene protein in hemangiomas.
O TM; Tan M; Tarango M; Fink L; Mihm M; Ma Y; Waner M
Otolaryngol Head Neck Surg; 2009 Aug; 141(2):213-8. PubMed ID: 19643254
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
Boone B; Haspeslagh M; Brochez L
J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
[TBL] [Abstract][Full Text] [Related]
3. Expression of glucocorticoid receptor isoforms in cutaneous hemangiomas and vascular malformations.
Jiang XW; Wang GH; Li JH; Chen ZX; He F
Chin Med J (Engl); 2005 Jun; 118(12):977-81. PubMed ID: 15978204
[TBL] [Abstract][Full Text] [Related]
4. A postulated role for transcriptional regulator LMO2 in the proliferation and involution of hemangioma.
Sun ZJ; Zhang L; Zhao YF
Med Hypotheses; 2006; 67(5):1230-2. PubMed ID: 16793212
[TBL] [Abstract][Full Text] [Related]
5. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
Wang P; Chen Z; Meng ZQ; Fan J; Luo JM; Liang W; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Xu ZD; Liu LM
Carcinogenesis; 2009 Sep; 30(9):1497-506. PubMed ID: 19546161
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations--preliminary report.
Przewratil P; Sitkiewicz A; Wyka K; Andrzejewska E
Pediatr Dermatol; 2009; 26(4):399-404. PubMed ID: 19689513
[TBL] [Abstract][Full Text] [Related]
7. Benign vascular proliferations--an immunohistochemical and comparative study.
Dyduch G; Okoń K; Mierzyński W
Pol J Pathol; 2004; 55(2):59-64. PubMed ID: 15469208
[TBL] [Abstract][Full Text] [Related]
8. Growth characteristics of infantile hemangiomas: implications for management.
Chang LC; Haggstrom AN; Drolet BA; Baselga E; Chamlin SL; Garzon MC; Horii KA; Lucky AW; Mancini AJ; Metry DW; Nopper AJ; Frieden IJ;
Pediatrics; 2008 Aug; 122(2):360-7. PubMed ID: 18676554
[TBL] [Abstract][Full Text] [Related]
9. Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas.
Franke FE; Steger K; Marks A; Kutzner H; Mentzel T
J Cutan Pathol; 2004 May; 31(5):362-7. PubMed ID: 15059220
[TBL] [Abstract][Full Text] [Related]
10. Facial nerve hemangiomas: vascular tumors or malformations?
Benoit MM; North PE; McKenna MJ; Mihm MC; Johnson MM; Cunningham MJ
Otolaryngol Head Neck Surg; 2010 Jan; 142(1):108-14. PubMed ID: 20096233
[TBL] [Abstract][Full Text] [Related]
11. Expression of Wilms tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions.
Lawley LP; Cerimele F; Weiss SW; North P; Cohen C; Kozakewich HP; Mulliken JB; Arbiser JL
Arch Dermatol; 2005 Oct; 141(10):1297-300. PubMed ID: 16230568
[TBL] [Abstract][Full Text] [Related]
12. [Role of urinary basic fibroblast growth factor in differentiating hemangiomas from vascular malformation].
Zhang L; Lin XX; Qi ZL; Dong JS; Zou LJ; Dai CC; Li W; Wang W
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):186-8. PubMed ID: 16635349
[TBL] [Abstract][Full Text] [Related]
13. GLUT-1 in oral benign vascular lesions.
Johann AC; Salla JT; Gomez RS; de Aguiar MC; Gontijo B; Mesquita RA
Oral Dis; 2007 Jan; 13(1):51-5. PubMed ID: 17241430
[TBL] [Abstract][Full Text] [Related]
14. Potential roles of allograft inflammatory factor-1 in the pathogenesis of hemangiomas.
Jia J; Zhao YF; Zhao JH
Med Hypotheses; 2007; 68(2):288-90. PubMed ID: 17010532
[TBL] [Abstract][Full Text] [Related]
15. Increased apoptosis coincides with onset of involution in infantile hemangioma.
Razon MJ; Kräling BM; Mulliken JB; Bischoff J
Microcirculation; 1998; 5(2-3):189-95. PubMed ID: 9789259
[TBL] [Abstract][Full Text] [Related]
16. Expression of allograft inflammatory factor-1 and CD68 in haemangioma: implication in the progression of haemangioma.
Jia J; Bai Y; Fu K; Sun ZJ; Chen XM; Zhao YF
Br J Dermatol; 2008 Sep; 159(4):811-9. PubMed ID: 18647307
[TBL] [Abstract][Full Text] [Related]
17. From hamartoma to splenic hemangioma.
Szpor J; Dyduch G
Pol J Pathol; 2008; 59(1):33-41. PubMed ID: 18655369
[TBL] [Abstract][Full Text] [Related]
18. [The expression of CEACAM-1 and CXCL-14 in infantile hemangioma].
Xu GQ; Lü RR; Huo R; Guo X
Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 May; 26(3):195-8. PubMed ID: 20737948
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study.
Badi AN; Kerschner JE; North PE; Drolet BA; Messner A; Perkins JA
Int J Pediatr Otorhinolaryngol; 2009 Sep; 73(9):1187-91. PubMed ID: 19524305
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
